(Q57031012)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149608%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

editorial

0 references

title

Why is the response rate slow in ceftazidime therapy for melioidosis? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149608%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149608%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Savithri D Puthucheary

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149608%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149608%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149608%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149608%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149608%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

5-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149608%20AND%20SRC:MED&resulttype=core&format=json

Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.158

Septicaemic melioidosis: a review of 50 cases from Malaysia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.158

Halving of mortality of severe melioidosis by ceftazidime

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.158

Comparison of imipenem and ceftazidime as therapy for severe melioidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.158

The histopathology of human melioidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.158

Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: a possible mechanism for cell-to-cell spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.158

Kinetic studies of bioactive products nitric oxide and 8-iso-PGF(2alpha) in Burkholderia pseudomallei infected human macrophages, and their role in the intracellular survival of these organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.158

Variations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomallei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.158

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.158

Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.158

Outcomes of patients with melioidosis treated with meropenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.158

Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.158

21 January 2018

Identifiers

DOI

10.1586/ERI.11.158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149608%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference